Day: January 8, 2024

Celltrion to cancel about 1 pct of outstanding shares

SEOUL, Celltrion Inc., a South Korean pharmaceutical company, said Monday it has begun the process of cancelling about 1 percent of its outstanding shares worth some 500 billion won (US$379.8 million) to boost shareholder value.

The value of shares …

Read more

Recent News